iNOS expression and lethal prostate cancer in patients with localized disease

被引：0
|
作者：
Rider, Jennifer R. [1 ]
Erlandsson, Ann [2 ]
Vyas, Chirag [1 ]
Davidsson, Sabina [2 ]
Carlsson, Jessica [2 ]
Andersson, Swen-Olof [2 ]
Andren, Ove [2 ]
机构：
[1] Boston Univ, Sch Publ Hlth, Boston, MA USA
[2] Orebro Univ Hosp, Orebro, Sweden
来源：
CANCER RESEARCH | 2017年 / 77卷 / 22期
关键词：
D O I：
10.1158/1538-7445.NEWFRONT17-B26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B26
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Prognostic value of connexin43 expression in patients with clinically localized prostate cancer
    Benko, G.
    Spajic, B.
    Demirovic, A.
    Stimac, G.
    Kruslin, B.
    Tomas, D.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2011, 14 (01) : 90 - 95
  • [32] Prognostic value of connexin43 expression in patients with clinically localized prostate cancer
    G Benko
    B Spajić
    A Demirović
    G Štimac
    B Krus̆lin
    D Tomas
    Prostate Cancer and Prostatic Diseases, 2011, 14 : 90 - 95
  • [33] ANALYSIS OF GENE EXPRESSION IN PROSTATE CANCER: DEFINING THE LETHAL PHENOTYPE
    Hong, M. K.
    Amiry, N.
    Chua, J.
    Kerger, M.
    Haviv, I
    Costello, A. J.
    Hovens, C. M.
    Corcoran, N. M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 172 - 173
  • [34] Analysis of gene expression in prostate cancer: defining the lethal phenotype
    Hong, M. K. H.
    Amiry, N.
    Chua, J.
    Kerger, M.
    Haviv, I.
    Costello, A. J.
    Hovens, C. M.
    Corcoran, N. M.
    BJU INTERNATIONAL, 2011, 107 : 14 - 15
  • [35] EXPRESSION PROFILE OF MICRORNAS IN BOTH SERUMS AND PROSTATE SPECIMENS AFTER RADICAL PROSTATECTOMY IN PATIENTS WITH LOCALIZED PROSTATE CANCER
    Tibi, Brannwel
    Durand, Matthieu
    Mauduit, Claire
    Carpentier, Xavier
    Rouscoff, Yohann
    Lee, Ji Wann
    Marsaud, Alexandre
    Ambrosetti, Damien
    Michiels, Jean Francois
    Severac, Francois
    Quintens, Herve
    Mahate, Zeinab
    Wijeratne, Victoria
    Amiel, Jean
    Chevallier, Daniel
    Benahmed, Mohamed
    JOURNAL OF UROLOGY, 2014, 191 (04): : E815 - E815
  • [36] Prostate cancer screening and the management of clinically localized disease
    Wilt, Timothy J.
    Ahmed, Hashim U.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [37] Prostate cancer: Detection, staging, and treatment of localized disease
    Potter, SR
    Partin, AW
    SEMINARS IN ROENTGENOLOGY, 1999, 34 (04) : 269 - 283
  • [38] Integrated PDEF and Twist1 expression distinguishes lethal prostate cancer from an indolent disease
    Wang, Fengtian
    Koul, Sweaty
    Jaiswal, Parveen K.
    Shi, Runhua
    Mills, Glenn
    Koul, Hari K.
    CANCER RESEARCH, 2016, 76
  • [39] Histomorphological Changes in the Peritumoral Zone in Patients with Localized Prostate Cancer as Predictors of Disease Progression
    Bova, Ph S.
    Maksimov, A. Yu
    Karnaukhov, N. S.
    Kit, O. I.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2018, 10 (03) : 139 - 144
  • [40] Fear of cancer recurrence among patients with localized prostate cancer
    Bergerot, Cristiane Decat
    Williams, Stephen B.
    Klaassen, Zachary
    CANCER, 2021, 127 (22) : 4140 - 4141
12345